1-(2-{4-[5-Chloro-1-(4-fluorophenyl)-1H-indol-3-yl]-1-piperidinyl}ethyl)-2-imidazolidinone(CAS: 106516-24-9)

The compound 1-(2-{4-[5-Chloro-1-(4-fluorophenyl)-1H-indol-3-yl]-1-piperidinyl}ethyl)-2-imidazolidinone (CAS: 106516-24-9) is subject to various regulatory guidelines. In the European Union, it falls under the scope of the REACH regulation and must comply with the requirements for registration and safety data sheets. In the United States, it is also regulated by the EPA under the Toxic Substances Control Act (TSCA) and may require specific handling and reporting under the FDA guidelines for pharmaceuticals.

Alternatives to 1-(2-{4-[5-Chloro-1-(4-fluorophenyl)-1H-indol-3-yl]-1-piperidinyl}ethyl)-2-imidazolidinone (CAS: 106516-24-9) in synthesis include its analogs with different substituents, such as changing the fluorophenyl group to a chlorophenyl group. Common alternative reagents might include other indole derivatives or piperidine analogs. These alternatives can offer different chemical properties and synthetic pathways.

The market trend for 1-(2-{4-[5-Chloro-1-(4-fluorophenyl)-1H-indol-3-yl]-1-piperidinyl}ethyl)-2-imidazolidinone (CAS: 106516-24-9) is closely linked to the development of new drug candidates in oncology and neurology. Research in this compound is focusing on its potential as an antineoplastic agent. Market dynamics suggest an increasing interest in novel indole-based compounds for therapeutic applications, indicating a growing trend in drug discovery and development.

Waste containing 1-(2-{4-[5-Chloro-1-(4-fluorophenyl)-1H-indol-3-yl]-1-piperidinyl}ethyl)-2-imidazolidinone (CAS: 106516-24-9) should be managed according to the waste segregation and disposal regulations. Collection of waste should be done in leak-proof containers and stored separately. For incineration, it is recommended to follow approved protocols for hazardous waste. Professional waste disposal services should be used for final disposal to ensure compliance with environmental protection regulations.